Cardinal Health Inc (CAH) : Sio Capital Management added new position in Cardinal Health Inc during the most recent quarter end. The investment management firm now holds 134,633 shares of Cardinal Health Inc which is valued at $11,255,319 , the company said in a statement filed on Aug 15, 2016 with the SEC.Cardinal Health Inc makes up approximately 5.05% of Sio Capital Management’s portfolio.
Other Hedge Funds, Including , Laffer Investments reduced its stake in CAH by selling 5,920 shares or 25.87% in the most recent quarter. The Hedge Fund company now holds 16,963 shares of CAH which is valued at $1,418,107. Cardinal Health Inc makes up approx 0.44% of Laffer Investments’s portfolio.Blackrock Investment Management reduced its stake in CAH by selling 13,906 shares or 1.8% in the most recent quarter. The Hedge Fund company now holds 760,089 shares of CAH which is valued at $63,543,440. Cardinal Health Inc makes up approx 0.08% of Blackrock Investment Management’s portfolio.Pegasus Partners Ltd. boosted its stake in CAH in the latest quarter, The investment management firm added 195 additional shares and now holds a total of 30,000 shares of Cardinal Health Inc which is valued at $2,508,300. Cardinal Health Inc makes up approx 1.25% of Pegasus Partners Ltd.’s portfolio. Smith Asset Management Group Lp sold out all of its stake in CAH during the most recent quarter. The investment firm sold 133,100 shares of CAH which is valued $11,092,554.Capital One National Association reduced its stake in CAH by selling 4,485 shares or 7.56% in the most recent quarter. The Hedge Fund company now holds 54,827 shares of CAH which is valued at $4,566,541. Cardinal Health Inc makes up approx 0.36% of Capital One National Association’s portfolio.
Cardinal Health Inc opened for trading at $79.9 and hit $80.08 on the upside on Thursday, eventually ending the session at $79.7, with a gain of 0.04% or 0.03 points. The heightened volatility saw the trading volume jump to 16,38,044 shares. Company has a market cap of $25,392 M.
On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Investors should note that on Aug 8, 2016, Cardinal Health Inc announced a cash dividend of $0.4489. The company’s management has announced Sep 29, 2016 as the ex-dividend date and fixed the record date on Oct 3, 2016. The payable date has been fixed on Oct 15, 2016.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.